Wang P, Zhang Y, Xiang R, Yang J, et al. Foretinib is effective in acute myeloid leukemia by inhibiting FLT3 and overcoming secondary mutations that drive resistance to quizartinib and gilteritinib. Cancer Res 2024 Jan 17. doi: 10.1158/0008-5472.CAN-23-1534.
PMID: 38231480